Baktari MD artwork

3 NEW Studies Show MAJOR Differences Between Moderna and Pfizer Vaccines

Baktari MD

English - September 22, 2021 13:00 - 23 minutes - 16.5 MB - ★★★★★ - 1 rating
Education business entrepreneurship management how to start a business business strategies small business ideas business culture mentorship tips crash ceo school Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed


While it's true that all currently authorized and recommended COVID-19 vaccines are safe, effective, and reduce your risk of severe illness, there are new studies that show when compared with the Pfizer vaccine and Johnson & Johnson vaccine that: patients receive double the amount of antibodies from the Moderna vaccine , the Moderna vaccine has a higher percentage when preventing infection or hospitalization and the Moderna vaccine has a higher percentage in reducing breakthrough cases. What are the differences between the Moderna and Pfizer vaccines? Is the Moderna vaccine better than the Pfizer vaccine or the Johnson and Johnson vaccine? That answer has yet to be uncovered.  As a Medical Doctor who has spent years going over medical studies, I go over these three new studies and breakdown exactly what they mean so you can make an informed decision.

At this time the CDC does not recommend one vaccine over another. It is still better and recommended to get whatever vaccine is offered to you first.

The three studies showing this emerging data are:
1. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273: 

https://jamanetwork.com/journals/jama/fullarticle/2783797?guestAccessKey=6ead80fe-bf08-4d53-8c5c-607249932480&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=083021

2. Comparison of two highly-effective mRNA vaccines for COVID19 during periods of Alpha and Delta variant prevalence:

https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v2.full.pdf

3. Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021:

https://www.cdc.gov/mmwr/volumes/70/wr/mm7037e2.htm?s_cid=mm7037e2_w

Thank you for joining me on another episode of Baktari MD! Do you have a question regarding our healthcare system? Please leave your question in the comments below so I can make an episode about it. Also, I’d love to hear any suggestions you may have for future content.

For more information, please visit: jonathanbaktarimd.com
Sign up for my newsletter here: https://ns.jonathanbaktarimd.com/

SOCIAL:
Facebook: https://www.facebook.com/baktarimd
Instagram: https://www.instagram.com/baktarimd/
Twitter: https://twitter.com/BaktariMD
LinkedIn: https://www.linkedin.com/in/jonathan-baktarimd/

YouTube: https://www.youtube.com/c/baktarimd

Disclaimer: All information discussed or provided by Jonathan Baktari, M.D. (“Dr. Baktari”) and/or his affiliates/guests are for educational purposes only. The information discussed and provided is not a substitute for professional medical advice, diagnosis, or treatment.  Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical concern or condition. Never disregard professional medical advice or delay in seeking it because of any information discussed or provided by Dr. Baktari or his affiliates/guests!  If you think you may have a medical emergency, call 911 immediately.  All information concerning hospitals, physicians, insurers, and other healthcare-related companies is based on Dr. Baktari’s observations of the healthcare industry as a whole and do not reflect on any specific hospital, physician, insurer, or other healthcare-related company.

Twitter Mentions